Evidence map›Paper›PMID 40181430›Full record

ArticleJournal of cheminformatics2025

The evolution of open science in cheminformatics: a journey from closed systems to collaborative innovation.

Christoph Steinbeck

Abstract readLetter
In one paragraph

Article in Journal of cheminformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Christoph SteinbeckInstitute for Inorganic and Analytical Chemistry, Friedrich-Schiller-University, Jena, Germany. christoph.steinbeck@uni-jena.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cheminformatics has significantly transformed over the past four decades, evolving from a field dominated by proprietary systems to one increasingly embracing open science principles. In its early years, cheminformatics was characterised by commercial software and restricted data access, limiting collaboration and reproducibility. The advent of open-source software in the late 1990s and early 2000s, including tools such as the Chemistry Development Kit (CDK) and RDKit, played a crucial role in democratising computational chemistry. Open data initiatives, such as PubChem and NMRShiftDB, further enhanced accessibility by providing freely available chemical information, fostering transparency and interoperability and introducing key standards, such as the International Chemical Identifier (InChI), revolutionised data integration and retrieval across diverse platforms. Community-driven efforts, including the Blue Obelisk movement and Open Notebook Science, have promoted open methodologies and collaborative research. More recently, national data infrastructure projects like NFDI4Chem have aimed to standardise research data management in cheminformatics, ensuring the long-term sustainability of open science practices. The increasing adoption of the FAIR (Findable, Accessible, Interoperable, Reusable) principles has further reinforced data sharing and reuse in computational chemistry. Challenges remain, particularly in overcoming resistance to data sharing and ensuring sustainable funding for open projects. However, the trajectory of cheminformatics demonstrates that embracing openness enhances scientific integrity and accelerates discovery and innovation.

Identifiers

PMID40181430
PMCPMC11969984

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.